Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro

Neuroscience

Volumn 89, Issue 3, 1999, Pages 901-907

  Ebersberger, A ^a   Averbeck, B ^b   Messlinger, K ^b   Reeh, P W ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Migraine; Neurogenic inflammation; Neuropeptides; Pain; Visceral afferents

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; PROSTAGLANDIN E2; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DURA MATER; ELECTROSTIMULATION; HEADACHE; HORMONE DETERMINATION; HORMONE RELEASE; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; STIMULATION;

AFFERENT PATHWAYS; ANIMALS; ARACHNOID; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; DINOPROSTONE; DURA MATER; ELECTRIC STIMULATION; HEADACHE; HISTAMINE; INFLAMMATION; MALE; MIGRAINE DISORDERS; NEURONS, AFFERENT; NOCICEPTORS; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; SEROTONIN; SUBSTANCE P; TRIGEMINAL GANGLION; VASODILATION;

EID: 0032910607     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00366-2     Document Type: Article

References (62)

1. 2 release from rat skin, in vitro, upon stimulation with inflammatory mediators. Eur. J. Physiol. 433:1997;R32.
2. Averbeck B., Sauer S., Reeh P.W. Limits in neurogenic mediation of prostaglandin release in the rat skin in vitro. Soc. Neurosci. Abstr. 23:1997;1810.
3. Berridge M.J. Inositol triphosphate and calcium signalling. Nature. 361:1993;315-325.
4. Brain S.D., Williams T.J. Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature. 335:1988;73-75.
5. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 313:1985;54-56.
6. Bretag A.H. Synthetic interstitial fluid for isolated mammalian tissue. Life Sci. 8:1969;319-329.
7. Brune K., Reinke M., Lanz R., Peskar B.A. Monoclonal antibodies against E- and F-type prostaglandins. High specificity and sensitivity in conventional radioimmunoassays. Fedn Eur. biochem. Socs Lett. 186:1985;46-50.
8. Buzzi M.G., Carter W.B., Shimizu T., Heath H. III, Moskowitz M.A. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology. 30:1991;1193-1200.
9. Buzzi M.G., Moskowitz M.A. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br. J. Pharmac. 99:1990;202-206.
10. Buzzi M.G., Sakas D.E., Moskowitz M.A. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur. J. Pharmac. 165:1989;251-258.
11. Carmody J., Pawlak M., Messlinger K. Lack of a role of substance P in the control of dural arterial flow. Expl Brain Res. 111:1996;424-428.
12. Dimitriadou V., Buzzi M.G., Moskowitz M.A., Theoharides T.C. Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience. 44:1991;97-112.
13. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
14. Düring M. von, Bauersachs M., Böhmer B., Veh R.W., Andres K.H. Neuropeptide Y- and substance P-like immunoreactive nerve fibers in the rat dura mater encephali. Anat. Embryol. 182:1990;363-373.
15. Ebersberger A., Ringkamp M., Reeh P.W., Handwerker H.O. Recordings from brain stem neurons responding to chemical stimulation of the subarachnoid space. J. Neurophysiol. 77:1997;3122-3133.
16. Edvinsson L., Ekman R., Jansen I., McCulloch J., Uddman R. Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J. cerebr. Blood Flow Metab. 7:1987;720-728.
17. Edvinsson L., Goadsby P.J. Neuropeptides in migraine and cluster headache. Cephalalgia. 14:1994;320-327.
18. Edvinsson L., Uddman R. Adrenergic, cholinergic and peptidergic nerve fibres in dura mater - involvement in headache? Cephalalgia. 1:1981;175-179.
19. Edvinsson L., Rosendahl-Helgesen S., Uddman R. Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell Tiss. Res. 234:1983;1-7.
20. Fanciullacci M., Tramontana E., Del Bianco E., Alessandri M., Geppetti P. Low pH medium induces calcium dependent release of CGRP from sensory nerves of guinea-pig dural venous sinuses. Life Sci. 49:1991;27-30.
21. Geppetti P., Del Bianco E., Patacchini R., Santicioli P., Maggi C.A., Tramontana M. Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: mechanism of action and biological response. Neuroscience. 41:1991;295-301.
22. Goadsby P.J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neurol. 33:1993;48-56.
23. Goadsby P.J., Edvinsson L. Peripheral and central trigeminovascular activation in cats is blocked by the serotonin (5-HT)-1D receptor agonist 311C90. Headache. 34:1994;394-399.
24. Goadsby P.J., Edvinsson L., Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol. 23:1988;193-196.
25. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol. 28:1990;183-187.
26. Goldstein D.J., Wang O., Saper J.R., Stoltz R., Silberstein S.D., Mathew N.T. Ineffectiveness of neurokinin-1 antagonists in acute migraine: a crossover study. Cephalalgia. 17:1997;785-790.
27. Hardebo J.E. On pain mechanisms in cluster headache. Headache. 31:1990;138-151.
28. Hirayama Y., Yasumitsu R., Kawamura A., Fujii T. NK1 receptors mediate tachikinin-induced plasma extravasation in the rat knee joint. Agents Actions. 40:1993;171-175.
29. ++-dependent exocytosis in the soma of dorsal root ganglion neurons. Neuron. 17:1996;135-145.
30. Inoue H., Nagata N., Koshihara Y. Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear. Inflamm. Res. 45:1996;316-323.
31. Kaehler C.M., Herold M., Wiedermann C.J. Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J. Cell Physiol. 156:1993;579-587.
32. Kaube H., Hoskin K.L., Goadsby P.J. Inhibition by sumatriptan of central trigeminal neurons only after blood-brain barrier disruption. Br. J. Pharmac. 109:1993;788-792.
33. Keller J.T., Marfurt C.F. Peptidergic and serotoninergic innervation of the rat dura mater. J. comp. Neurol. 309:1991;515-534.
34. Kessler W., Kirchhoff C., Reeh P.W., Handwerker H.O. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Expl Brain Res. 91:1992;467-476.
35. 2 release from rat skin, in vitro, upon antidromic nerve stimulation. Neuroscience in press.
36. Kress M. and Reeh P. W. (1996) Chemical excitation and sensitization in nociceptors. In Neurobiology of Nociceptors (eds Belmonte C. and Cervero F.), pp. 258-297. Oxford University Press, Oxford.
37. Kurosawa M., Meßlinger K., Pawlak M., Schmidt R.F. Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br. J. Pharmac. 114:1995;1397-1402.
38. 2. Nature. 258:1975;337-339.
39. Markowitz S., Saito K., Moskowitz M.A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:1987;4129-4136.
40. McCulloch J., Uddman R., Kingman T.A., Edvinsson L. Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc. natn. Acad. Sci. U.S.A. 83:1986;5731-5735.
41. Messlinger K., Hanesch U., Baumgärtel M., Trost B., Schmidt R.F. Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat. Embryol. 188:1993;219-237.
42. 2-induced sensitization of the heat response of canine visceral polymodal receptors in vitro. Neurosci. Lett. 161:1993;117-119.
43. Moskowitz M. A. and Cutrer F. M. (1994) Possible importance of neurogenic inflammation within the meninges to migraine headaches. In Progress in Pain Research and Management (eds Fields H. L. and Liebeskind J. C.), Vol. 1, pp. 43-49. IASP, Seattle.
44. 1 receptor antagonist, RP 67580. Eur. J. Pharmac. 238:1993;421-424.
45. Nagahisa A., Kanai Y., Suga O., Taniguchi K., Tsuchiya M., Lowe J.A. III, Hess H.J. Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. Eur. J. Pharmac. 217:1992;191-195.
46. Noda S., Hoh H., Umezaki H., Fukuda Y. Successful treatment of migraine attacks with intravenous injection of aspirin. J. Neurol. Neurosurg. Psychiat. 48:1985;1187.
47. 2 in the saliva of common migraine patients. Action of calcium channel blockers. Headache. 8:1989;498-501.
48. Olesen J., Friberg L., Skyhoi-Olsen T., Iversen H.K., Lassen N.A., Andersen A.R., Karle A. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann. Neurol. 28:1990;791-798.
49. 1 receptors mediate plasma protein extravasation in guinea-pig dura. Eur. J. Pharmac. 236:1993;319-321.
50. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
51. Rich G., Yoder E.J., Prokuski L., Moore S.A. Prostaglandin production in cultured cerebral microvasculature smooth muscle is serum dependent. Am. J. Physiol. 270:1996;C1379-C1387.
52. Ringkamp M., Schmelz M., Kress M., Allwang M., Ogilvie A., Reeh P.W. Activated human platelets in plasma excite nociceptors in rat skin, in vitro. Neurosci. Lett. 170:1994;103-106.
53. 2. J. Physiol., Lond. 403:1988;91-104.
54. 1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br. J. Pharmac. 108:1993;11-12.
55. Steen K.H., Steen A.E., Reeh P.W. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J. Neurosci. 15:1995;3982-3989.
56. Strassman A.M., Raymond S.A., Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 384:1996;560-564.
57. 2 levels in the saliva of common migraineous women. Headache. 23:1983;59-61.
58. 2 enhances bradykinin stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 14:1994;4987-4997.
59. 2 substitution restores chemical responsiveness of nociceptors in prostanoid deprived rabbit pleura, in vitro. Pflügers Arch. 431:1996;P106.
60. Zagami A.S., Goadsby P.J., Edvinsson L. Extracranial peptide release following stimulation of the superior sagittal sinus in the cat. Cephalalgia. 9:1989;294-295.
61. Zagami A.S., Goadsby P.J., Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive petides. Neuropeptides. 16:1990;69-75.
62. 2+ permeability of the sustained proton-induced cation current in adult rat dorsal root ganglion neurons. J. Neurophysiol. 76:1996;2834-2840.